News | News By Subject | News by Disease News By Date | Search News

 News

Get Our FREE
Industry eNewsletter
email:    
Top Breaking News
6 (Plus 2!) Most Notable ASCO Abstracts So Far     5/22/2017
5 Biotechs Releasing Highly-Anticipated Data at ASCO     5/19/2017
GlycoMimetics (GLYC) Stock Takes Off on Positive Phase II Leukemia Data, Breakthrough Tag     5/18/2017
FDA Slaps Clinical Hold on Concert Pharma (CNCE)'s Hair Loss Drug     5/18/2017
SoCal's Capricor to Reduce Workforce and Shift Focus After Discouraging Trial Results     5/12/2017
4 Biotechs That Could Release Stock-Shattering Data Soon     5/11/2017
Catastrophic Year for Bay Area's OncoMed (OMED) Continues as Lead Drug Comes Crashing Down in Phase II Study     5/9/2017
3 Cancer Biotechs to Watch at ASCO     5/9/2017
Is This Fake News? Neurotrope (NTRP) Alzheimer's Release Takes Weird Spin     5/5/2017
Gilead (GILD)'s $600 Million NASH Deal Finally Bears Fruit     4/26/2017
Novartis AG (NVS) Remains Hush-Hush About CAR-T Trial But the FDA is Impressed and Thinks It's a Breakthrough     4/20/2017
Why Former Medivation (MDVN) CEO and a Once-Failed Alzheimer's Drug Could be a Recipe for Disaster for Axovant (AXON)     4/20/2017
This Year’s Superbug Norovirus Sickens Hundreds of Millions, Prompting Urgent Race for Vaccine     4/18/2017
When It Rains, It Pours: Bay Area's OncoMed (OMED) Tanks Again as Lung Cancer Med Fails Phase II, Discontinues Phase I Study     4/18/2017
3 Drug Giants That Boasts the Best Pipelines     4/11/2017

Featured Stories
Cara Therapeutics (CARA): A Look At The Next Catalyst—Osteoarthritis     5/16/2017
TG Therapeutics (TGTX): Significant Near-Term Catalysts For 2017     5/16/2017
4 Biotechs That Could Explode Or Crash In May     5/5/2017
A New Weapon In The War Against Opioid Abuse?     5/4/2017
Finally! Novartis AG (NVS) To Release Long-Awaited Juliet CAR-T Data In June     4/25/2017
Top 15 R&D Spenders In The World For 2017     4/24/2017
Can Psoriatic Arthritis Lift Gilead (GILD)'s Sinking Ship?     4/20/2017
Matinas BioPharma's Weak Drug Pipeline And Investors With Fraudulent Histories     3/27/2017
This Cheap Michigan Biotech Could Have Major Phase II Catalysts Coming     3/20/2017
Why Ionis Pharma (IONS)'s Extensive And Deep Pipeline Could Get Investors' Hearts Pumping     3/8/2017
An Expected Failure From Karyopharm (KPTI)'s Selinexor Doesn't Change The Bull Thesis     3/6/2017
Roche (RHHBY)'s Renal Success Spells Danger For All-Comer Studies     2/27/2017
Why 2017 Will be a Data-Rich and Not Revenue-Focused Year for bluebird bio (BLUE)     2/24/2017
Could Marijuana Be the Next Miracle Drug For Treating Cancer?     2/20/2017
Allergan (AGN) R&D Chief Reveals 6 Drugs That Could be Potential Blockbusters     2/14/2017
Shire (SHPG)'s Hemophilia A Drug Flunks Tiny Phase I Trial     5/22/2017
Myovant (MYOV) Announces Presentation Of Positive Phase II Data For Relugolix In Women With Endometriosis-Associated Pain At The World Congress On Endometriosis     5/22/2017
Arbutus Biopharma (ABUS) Presents HBV Drug Combination Studies At ICAR     5/22/2017
Versartis (VSAR) Presents 3-Year Somavaratan Safety And Efficacy Data And Pediatric Program Baseline Demographics At The 19th European Congress Of Endocrinology     5/22/2017
Anavex (AVXL) Reports New Data For ANAVEX 2-73 In Neurodevelopmental Disorders Including Angelman Syndrome: Data Presented At Antiepileptic Drug Trials XIV 2017 Conference     5/22/2017
Merck & Co. (MRK) Announces Presentation Of Phase II Results For MK-7264, An Investigational, P2X3 Receptor Antagonist, Being Evaluated For The Treatment Of Chronic Cough     5/22/2017
AM-Pharma Completes Patient Recruitment Of Recombinant Human Alkaline Phosphatase (recAP) Phase II Trial In Acute Kidney Injury     5/22/2017
Xynomic Pharma And UCSF Entered Strategic Partnership In Conducting A Phase II/III Trial Of Abexinostat Against Renal Cell Carcinoma     5/22/2017
Revance (RVNC) Announces Positive Top-Line 24-Week Duration Of Effect Results In All Three Cohorts In RT002 Injectable Phase II Cervical Dystonia Trial     5/19/2017
Aldeyra (ALDX) Presents Noninfectious Anterior Uveitis Phase II Clinical Trial Data At Association for Research in Vision & Ophthalmology 2017 Annual Meeting     5/19/2017
Nordic Nanovector Release: Safety Review Committee Approves The Continued Evaluation Of The 20 Mbq/Kg Betalutin With 100 Mg/M2 Lilotomab Regimen In Phase ll Cohort In NHL     5/19/2017
Polyphor Announces Successful End Of Phase II Meeting With FDA For Murepavadin In Nosocomial Pneumonia     5/19/2017
Soligenix (SNGX) Announces Publication Of Its Phase II Long-term Follow-up Results Of SGX942 For The Treatment Of Oral Mucositis In Head And Neck Cancer Patients     5/18/2017
Myovant (MYOV) Announces Upcoming Presentations Of Relugolix Data From Phase II Trial In Women With Endometriosis-Associated Pain     5/18/2017
CASI Pharma (CASI) Announces Abstract On ENMD-2076 In Clear Cell Ovarian Cancer     5/18/2017

More News
No News Posted on that date

Career Tips
Size Matters: Why a Biotech's Size Can Affect Your Career     5/12/2017
Interview Insider: Tips on How to Get Hired at Johnson & Johnson (JNJ), Bristol-Myers Squibb (BMY), and Novartis AG (NVS)     5/12/2017
Top 5 Jobs for Introverted Life Scientists     5/12/2017
What It's Like To Work For Drug Giant Sanofi (SNY)     5/11/2017
The Tide Is Turning For Biomedical Sciences Training     5/11/2017
How Scientists Can Transition Into A Non-Research Career     5/11/2017
Sweet Revenge: Job Prospects Great For Science Geeks And Nerds     5/11/2017
How To Resign From Your Life Sciences Job     5/11/2017
5 Steps to Prep Your Resume for a Career Event     5/8/2017
How to Prepare for a Talent Connect Career Event     5/1/2017
This Is By Far the #1 Highest Paying Non-Executive Biotech Job in the U.S.     5/1/2017
Top 10 R&D Scientist Skills in Demand     5/1/2017
The Biotech Job Title You've Probably Never Heard Of     5/1/2017
Do Aging Scientists Limit Job Opportunities For Young Researchers?     4/22/2017
How Using Recruiters Can Benefit Your Life Science Job Search     4/22/2017

Other News Sources
//-->